NLRP3 and Alzheimer disease: In 3xTg AD mice model, the inhibition of IL-1β receptor by injection of blocking antibodies results in reduced tau kinase activity and ameliorates the cognitive impairment, implying that NLRP3 inflammasome activation exacerbates tau phosphorylation and subsequent neuronal damage (Kitazawa et al., 2011).